• A Cost-effectiveness analysis of Antipsychotics for treatment of Schizophrenia in Uganda

    May 1, 2015, 00:00

  • Evaluation Of A Pharmaceutical Risk-Sharing Agreement When Patients Are Screened For The Probability Of Success

    May 1, 2015, 00:00

  • Bone Pain, Skeletal Related Events and Opioid Use in Patients With Prostate Cancer And Bone Metastases

    May 1, 2015, 00:00

  • Assessment Of Level Of Medication Adherence In Different Non-Communicable Chronic Diseases Patient In Quetta, Pakistan- Dose Disease Condition Produces Any Change

    May 1, 2015, 00:00

  • Evaluation of Audit scoring Consistency in a comprehensive feedlot Management System and correlation with feedyard performance based on average daily Gain and Dry feed conversion in 11 US feedlots

    May 1, 2015, 00:00

  • Trends associated with Implementing and Lifting a step Therapy Policy for pregabalin in the humana Medicare Population- an Interrupted time series analysis

    May 1, 2015, 00:00

  • Transfusion-Related Acute Lung Injury (Trali) Occurrence Among Inpatient Medicaid Beneficiaries, Under 65 Years of Age, As Recorded By Large Administrative Databases During 2007-2010

    May 1, 2015, 00:00

  • Tree-Based Claims Algorithm For Measuring Pre-Treatment Quality Of Care In Medicare Disabled Hepatitis C Patients

    May 1, 2015, 00:00

  • Health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in treatment-naÏve adults with Genotype 1B (GT1B) Chronic Hepatitis C

    May 1, 2015, 00:00

  • Implications Of The Inter-Relatedness Of The Proportional And Absolute Qaly Shortfall Measurements For Disease Burden

    May 1, 2015, 00:00

  • An Indirect Comparison of Iwqol-Lite total Score Change In Subjects treated with Canagliflozin, Exenatide qw, Sitagliptin, or Pioglitazone In dual Therapy With Background Metformin

    May 1, 2015, 00:00

  • Us Burden of Illness Associated With Adjuvant Therapy for Stage I-III Melanoma

    May 1, 2015, 00:00

  • Assessing the economic burden of u.s. Medicare patients diagnosed with non-hodgkin’s lymphoma

    May 1, 2015, 00:00

  • Humanistic Burden of Chronic Spontaneous Urticaria In Comparison to Psoriasis- US And European Perspective

    May 1, 2015, 00:00

  • Generic Drug Discount Programs And Their Potential Impact On The Completeness Of Pharmacy Claims Data

    May 1, 2015, 00:00

  • Suggestion Of New Methods To Calculate Confidence Interval For Incremental Cost-Effectiveness Ratio Which Solve The Issues With Conventional Method

    May 1, 2015, 00:00

  • Prevalence of Mental Health Disorders and access to care among children Enrolled in the mississippi medicaid

    May 1, 2015, 00:00

  • United States decision maker perceptions of data from observational studies and other Health Economics and outcomes research

    May 1, 2015, 00:00

  • Functional Status And Difficulty In Activities Of Daily Living Among Aging Population Of India

    May 1, 2015, 00:00

  • Differences in Breast Cancer screening rates in medicare advantage non-dual eligible members, dual eligibles enrolled in special need plans and other Healthcare Plans

    May 1, 2015, 00:00

  • Cost-Minimization analysis of Infliximab versus Adalimumab in the treatment of Crohn’s disease and Ulcerative Colitis

    May 1, 2015, 00:00

  • Comparison Of Different Metabolic Syndrome Criteria And Individual Risk Factors In The Risk Prediction Of Cardiovascular And Chronic Diseases

    May 1, 2015, 00:00

  • Impact of tolerability profiles on HTA decision making in Oncology

    May 1, 2015, 00:00

  • Economic Analysis of Biologic Alternatives In The Management of Rheumatoid Arthritis, Psoriasis and ankylosing Spondylitis From Public and Private Perspectives in Brazil

    May 1, 2015, 00:00

  • Availability and Use of Epinephrine Auto-Injectors for The Treatment of Anaphylaxis- Results From The Epipen4schoolsâ® Survey

    May 1, 2015, 00:00

  • Trends in the prevalence of Dementia among the Medicare Beneficiaries- 2001-2010

    May 1, 2015, 00:00

  • Understanding the average svr rates of hepatitis c treatments and their implications on clinical and economic outcomes- then vs. Now

    May 1, 2015, 00:00

  • Quality of Life of Patients With Parkinson’s Disease And Other Neurodegenerative Disorders

    May 1, 2015, 00:00

  • Peripheral arterial disease management program- screening-risk factor management program and financial return on investment

    May 1, 2015, 00:00

  • Common reasons for and associated costs of Pediatric inpatient admissions in the United States

    May 1, 2015, 00:00

  • The validity of the Proportional Hazards assumption for the meta-analysis of time to event data to support submissions to Health Technology Assessment (HTA) authorities

    May 1, 2015, 00:00

  • A System dynamics model for the cost-effectiveness evaluation of Bacterial whole-genome sequencing for detecting and monitoring outbreaks of MRSA

    May 1, 2015, 00:00

  • The value of non-randomised evidence for informing Clinical effectiveness- an assessment of HTA requirements and Published Guidance regarding the appropriateness of non-randomised data

    May 1, 2015, 00:00

  • Knowledge, attitude and perceptions of Hospital Pharmacists towards pharmacists led interventions to reduce adverse Drug reactions, Drug interactions, and Pharmaceutical care issues towards better Pharmaceutical care planning- a qualitative ...

    May 1, 2015, 00:00

  • Factors Predicting Receipt of Prostate Specific Antigen (PSA) Testing- Evidence from the national ambulatory Medical Care Survey (Namcs) data

    May 1, 2015, 00:00

  • A DESCRIPTIVE ANALYSIS OF TIME TO FIRST TREATMENT WITH DISEASE-MODIFYING DRUGS (DMDS) IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE SCLEROSIS (MS)

    May 1, 2015, 00:00

  • Federal exchanges provide Lower Premiums but Less Generous Pharmacy benefits than Employer-Sponsored Plans

    May 1, 2015, 00:00

  • Metformin and Intensive lifestyle intervention for pre-diabetes - systemati Review of Efficacy

    May 1, 2015, 00:00

  • Use of consumer market research panels to generate prevalence and disease burden estimates in data-sparse diseases- a case study in severe Chronic Hand Eczema

    May 1, 2015, 00:00

  • Healthcare Resource Utilization associated with dalfampridine Extended Release In Multiple Sclerosis- A Retrospective Claims Database Analysis

    May 1, 2015, 00:00

  • Direct Medical Costs Of Her2 Positive Breast Cancer Management In Iran- A Claims Database And Data Mining Analysis

    May 1, 2015, 00:00

  • Expansion of current HPV Vaccination guidelines to include Men who have Sex with Men who are 27 years or older – a value of information analysis

    May 1, 2015, 00:00

  • The Effect of ras-Modifying Medications on Pulmonary Health In Patients with Type 2 Diabetes mellitus

    May 1, 2015, 00:00

  • Bone Safety Profile of Denosumab Therapy- a Pharmacovigilance Characterization Analysis

    May 1, 2015, 00:00

  • Will U.S. payers Champion Biosimilars?

    May 1, 2015, 00:00

  • Economic Aspects of Influenza Vaccination In Ukraine

    May 1, 2015, 00:00

  • Classification Tree Analysis Of The Likelihood Of Clopidogrel Treatment In A Cohort Of Patients With Symptomatic Peripheral Artery Disease

    May 1, 2015, 00:00

  • Use of infliximab within a Patient support program- positive perception of iv Infusions from Patients’ perspective

    May 1, 2015, 00:00

  • Choosing between the promis global and eq-5d for comparative effectiveness research- are they really different?

    May 1, 2015, 00:00

  • A Retrospective Cohort Study to investigate actual treatment for Glaucoma using a Japanese Healthcare Database

    May 1, 2015, 00:00

  • Impact of Young-onset Parkinson’s Disease on Quality of Life €“ a Literature Review

    May 1, 2015, 00:00

  • Possibilities Of Childhood Vaccinations

    May 1, 2015, 00:00

  • Direct costs comparison of medical care before and after Heart failure Hospitalization in a Medicare Population

    May 1, 2015, 00:00

  • The impact of early medicare administrative contractor implementation on the receipt of Chemotherapy and Biologic agents by medicare colon Cancer beneficiaries with Metastatic Disease

    May 1, 2015, 00:00

  • A Review of Methodologies used to assess adherence to Disease Modifying Therapies among Patients with Multiple Sclerosis

    May 1, 2015, 00:00

  • The Impact of Negative Trial Results on The Use of Blood Transfusions

    May 1, 2015, 00:00

  • Lack Of Adherence To Immunosuppressive Treatment In Kidney Transplant Patients- Computer Assisted Qualitative Data Analysis (Caqdas) Of An Expert Panel

    May 1, 2015, 00:00

  • Hospital budget impact of sugammadex (Bridionâ®) for Reversal of Neuromuscular Blockade

    May 1, 2015, 00:00

  • Predictors of Cigarette Smoking in Three Asian Countries- China India and Taiwan

    May 1, 2015, 00:00

  • The Incremental Cost Of Reoperations For Bleeding Events In Cardiac And Vascular Reconstructive Surgery

    May 1, 2015, 00:00

  • Cost-effectiveness of AQP4 antibody detection with cell-based assay compared with elisa for devic disease Diagnosis in Colombia

    May 1, 2015, 00:00

  • Economic evaluation of paclitaxel-eluting balloon catheter for Percutaneous Transluminal Angioplasty (PTA) in Mexican Population with Peripheral Arterial Obstructive Disease

    May 1, 2015, 00:00

  • Will flat EU Pricing become a reality? considerations for the Biopharma industry and whether future EU pricing transparency rules will affect the Current position

    May 1, 2015, 00:00

  • Alemtuzumab Budget Impact Analysis in Relapsing-Remitting Multiple Sclerosis in the US

    May 1, 2015, 00:00

  • Utilizing Electronic Medical Record Networks For Identifying Patients For Clinical Trial Recruitment

    May 1, 2015, 00:00

  • Characteristics of Products with Price changes after a policy change in Egypt

    May 1, 2015, 00:00

  • Gender-specific safety outcome reports for New Molecular entity Drugs

    May 1, 2015, 00:00

  • The Use Of Statins Among Prior-Users After Hemodialysis

    May 1, 2015, 00:00

  • Quality of evidence supporting inclusion of Pharmacogenomic biomarkers in product labels of fda approved Oncology Therapies

    May 1, 2015, 00:00

  • Patient recall following Breast Cancer screening Mammography among medicaid patients by patient race

    May 1, 2015, 00:00

  • Assessing The Variables Affecting The Completion Of A Compliance Monitoring Program (Cmp) For Nurses Undergoing Substance Abuse Treatment

    May 1, 2015, 00:00

  • Investigation Of Relationships Between Biomarkers Of Potential Harm And Cigarette Smoking Measures Among Current, Past, And Non-Smokers Based On National Health And Nutrition Examination Survey 2007-2012

    May 1, 2015, 00:00

  • Budget Impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple Sclerosis

    May 1, 2015, 00:00

  • Estimating The Budget Impact Of Clevidipine For The Management Of Perioperative Blood Pressure In Cardiac Surgery- A Us Perspective

    May 1, 2015, 00:00

  • Can serologic markers of Fibrosis predict future shocks in ICD recipients with dilated Cardiomyopathy?

    May 1, 2015, 00:00

  • Adherence and persistence to anti-epileptic drugs among u.s. Veterans diagnosed with epilepsy

    May 1, 2015, 00:00

  • Determining patterns of Opioid misuse and misprescribing in South Carolina

    May 1, 2015, 00:00

  • Impact of a pharmacist medication adherence consultation program on health care costs and risk of hospitalization

    May 1, 2015, 00:00

  • Comparison of disease status and outcomes of Patients with Ankylosing Spondylitis (AS) receiving adalimumab or Etanercept Monotherapy in the United States (US)

    May 1, 2015, 00:00

  • Specialty tier cost sharing and use of disease modifying Therapies Among Medicare Beneficiaries with Multiple Sclerosis

    May 1, 2015, 00:00

  • Prevalence of Medication use not captured by prescription claims databases – an analysis using 2012 Medical Expenditure Panel Survey Data

    May 1, 2015, 00:00

  • Chilean Valuation Of The Eq-5d Health States

    May 1, 2015, 00:00

  • Evaluation of the Quality of Life of Diabetic Patients in Minas Gerais State, Brazil

    May 1, 2015, 00:00

  • Literature review of the use of ICER thresholds in Healthcare decision-making

    May 1, 2015, 00:00

  • Identification and Characterization of Long Term Survival Population In Non-Small-Cell Lung Cancer Patients Treated With Immunotherapies

    May 1, 2015, 00:00

  • Five-year impact of Depression on life-satisfaction and The Protective Influence of Social Support

    May 1, 2015, 00:00

  • Eliciting Patient Treatment Preferences- Development Of A Methodological Framework For Attribute Identification And Validation For Discrete Choice Experiments

    May 1, 2015, 00:00

  • Patients In The Waiting List Of Bariatric Surgery In The Brazilian Public Sector Treatment Patterns And Health Outcomes- A Non-Interventional Single-Site Retrospective Study

    May 1, 2015, 00:00

  • DEVELOPMENT, VALIDATION, AND ANALYSIS OF A LINEAR REGRESSION MODEL PREDICTING CHILD’S BIRTHWEIGHT FROM MOTHER’S RACE, EDUCATION LEVEL, SMOKING STATUS, AND GESTATION AGE

    May 1, 2015, 00:00

  • Systematic Literature Review Of Cost Of Adverse Events In Cancer Treatments In The Us

    May 1, 2015, 00:00

  • Bayesian network Meta-Analysis (Nma) to Assess the relative Efficacy of Canagliflozin Monotherapy over 26 weeks In Patients with Type 2 Diabetes mellitus (T2dm)

    May 1, 2015, 00:00

  • Tackling the tariff for Sofosbuvir In hcv – Indispensable Innovation Versus Budget-Busting Potential

    May 1, 2015, 00:00

  • An Innovative Cloud-Based Platform for Implementing Performance-Based Risk-Sharing Arrangements (Pbrsas) in Oncology Settings

    May 1, 2015, 00:00

  • Healthcare Coverage, Expenditures and Population Habits in Argentina

    May 1, 2015, 00:00

  • Developing Hospital Based Hta For Egyptian Cancer Patients

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain

    May 1, 2015, 00:00

  • Analysis of Adverse Drug Reactions During Pharmacotherapeutic Follow-Up of Hiv+ Patients

    May 1, 2015, 00:00

  • Description of Patients satisfaction or dissatisfaction with referral and counter referral process

    May 1, 2015, 00:00

  • Overview and importance of nub process for Market Access of in-patient Drugs and devices in Germany

    May 1, 2015, 00:00

  • Cost-effectiveness of treating Hepatitis C Virus (HCV) Genotype 1 (GT1) patients with abbvie 3D (Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir) +/- ribavirin compared to harvoni (Sofosbuvir/Ledipasvir) in the United States

    May 1, 2015, 00:00

  • Treatment of acute Appendicitis in Germany- results of the analysis of a Health Insurance claims database

    May 1, 2015, 00:00

  • Cost-effectiveness of Secukinumab compared to current treatments for the treatment of moderate to severe plaque Psoriasis in Canada

    May 1, 2015, 00:00

  • Predicting Phase Iii Survival outcomes Using Phase Ii Trial Data In Nsclc and Rcc

    May 1, 2015, 00:00

  • Relationship of Serum Uric Acid Levels With Hypertension And Hyperlipidemia In Patients With Gout

    May 1, 2015, 00:00

  • Optimising market access of Cancer Drugs in Canada- a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee

    May 1, 2015, 00:00

  • Geographic Differences In Availability Of Antihypertensive Medications- A Comparison Of Australia, Canada, Saudi Arabia, Uk, And The Us

    May 1, 2015, 00:00

  • The Electronic Age- Integrating Epro/Ecoa To Reduce Patient, Site, And Study Team Burden

    May 1, 2015, 00:00

  • Healthcare Resource utilization and Medical Care Cost Associated With New Bio-Surgical Hemostasis In China

    May 1, 2015, 00:00

  • Evaluating The Outcomes of A Diabetes Treatment Management Program Targeting Appropriate Anti-Hypertensive Treatment For Adults With Diabetes for Dual And Non-Dual Eligible Medicare Advantage Beneficiaries

    May 1, 2015, 00:00

  • Treatment outcomes of Smear Positive Pulmonary TB Cases Registered In TB Patients In Quetta

    May 1, 2015, 00:00

  • Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In Turkey

    May 1, 2015, 00:00

  • Modelling The Cost Determinants For Older Persons’ Transitions In Care (Optic)

    May 1, 2015, 00:00

  • Impact of New changes due to Affordable care act on US Market Access

    May 1, 2015, 00:00

  • Hospital Utilization In Patients With Ebstein’s Anomaly

    May 1, 2015, 00:00

  • Timing of eu5 US Orphan Drug approvals and PRMA between 2009 and 2013

    May 1, 2015, 00:00

  • Effect of Patient’s cost sharing on Expenditures- an Instrumental Variables Approach

    May 1, 2015, 00:00

  • Systematic Review of Epidemiology and Burden of Pancreatic Cancer

    May 1, 2015, 00:00

  • Characteristics of Combination Pharmacotherapy in Patients with Diabetic Painful Neuropathy (DPN)

    May 1, 2015, 00:00

  • Use of Anti-osteoporosis Medications and Fracture Risk Among Elderly Patients With End-Stage Renal Disease- A Retrospective Cohort Study

    May 1, 2015, 00:00

  • Out-of-pocket Healthcare Expenditures among patients with Chronic obstructive Pulmonary disease

    May 1, 2015, 00:00

  • Cross section analysis of Marginal NHS expenditure by England Health area

    May 1, 2015, 00:00

  • Direct medical costs associated with Clinical and Health characteristics in visually impaired individuals in Singapore

    May 1, 2015, 00:00

  • Estimating the cost of Pneumonia cases admitted at the internal medicine wards of a tertiary Government Hospital in the Philippines

    May 1, 2015, 00:00

  • CRITICAL PROBLEMS OF CODING DATA IN HEALTH CARE- OBESITY, SMOKING, AND ALCOHOL USE BY METHOD OF MEASUREMENT

    May 1, 2015, 00:00

  • Effectiveness And Cost-Effectiveness Of Catheter-Directed Thrombolysis In Massive Pulmonary Embolism

    May 1, 2015, 00:00

  • Do depression rates differ by conflict era among War Veterans?

    May 1, 2015, 00:00

  • Loss of Productivity Costs Attributable to Being overweight or Obese In Working Asthma Patients In The Us

    May 1, 2015, 00:00

  • Patient- and Physician-Reported Motivations for Medication Non-Adherence or Switching In Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Assessment Of Drug Utilization Pattern And Clinical Outcome In Pregnancy Induced Hypertension In Teritary Care Hospital

    May 1, 2015, 00:00

  • Diabetes Mellitus Treatment- Cost-Effectiveness of Schemes Therapeutic Glargine and Nph - Brazil, 2014

    May 1, 2015, 00:00

  • Current Situation Of The Public-Private Partnerships For Drugs In Brazil

    May 1, 2015, 00:00

  • Effects of Overweight and Obesity on Health service use and expenditures among U.S. adults with Chronic renal disease

    May 1, 2015, 00:00

  • Estimating Clinical and Economic Outcomes Following a Diabetes-Related vascular Complication

    May 1, 2015, 00:00

  • Pharmacotherapy Optimization plan for patients with type-2 Diabetes mellitus (T2DM) and Hypertension in a Chilean Healthcare setting- impact and outcomes

    May 1, 2015, 00:00

  • Comparison of the impact of Human versus analogue insulins on Glycosylated Hemoglobin in a Population with Diabetes Mellitus Colombia

    May 1, 2015, 00:00

  • Economic impact of using Harmonic Scalpel Technology in Surgery

    May 1, 2015, 00:00

  • Analysis Of Treatment Cost For Uterine Fibroids In Ukraine

    May 1, 2015, 00:00

  • Sex Differences In over-the-counter sleep aid use in older adults

    May 1, 2015, 00:00

  • Cost per additional responder associated with Biologic use in Psoriasis

    May 1, 2015, 00:00

  • Universal screening identifies higher Thyroid Dysfunction in pregnancy. evidence based meta-analysis

    May 1, 2015, 00:00

  • Estimating the Health Benefits of Meeting the Healthy People 2020 objectives for reducing Invasive Colorectal Cancer Incidence In the united states

    May 1, 2015, 00:00

  • Predictors of Allopurinol adherence in patients with Gout

    May 1, 2015, 00:00

  • Unmet needs and treatment patterns in Lupus- results from an online Community

    May 1, 2015, 00:00

  • Evaluating The Economic Implications of Nonadherence And Antibody-Mediated Rejection In Renal Transplant Recipients- The Role of Once-Daily, Prolonged-Release Tacrolimus In The Uk Setting

    May 1, 2015, 00:00

  • Health economic model to measure the impact of a stemi initiative in Romania

    May 1, 2015, 00:00

  • FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

    May 1, 2015, 00:00

  • Invariance of Quality of Life Questionnaire Eortc Qlqc30 In Different Cancer Indications

    May 1, 2015, 00:00

  • Public Perspectives On Cost-Related Non-Adherence Among Patients

    May 1, 2015, 00:00

  • Treatment for substance use and implications for Mortality in elderly prostate Cancer Patients

    May 1, 2015, 00:00

  • Improved Heor writing skills of keen interest to Bio/Pharma Heor Directors and Managers

    May 1, 2015, 00:00

  • Application Of Difference-In-Difference Methodology In Comparative Effectiveness Research With Unbalanced Groups

    May 1, 2015, 00:00

  • Real-World Outcomes of Acute Ischemic Stroke Patients In The Medicare Population

    May 1, 2015, 00:00

  • Humanistic and Economic outcomes among patients receiving Percutaneous Intervention

    May 1, 2015, 00:00

  • Use of Clozapine and Antipsychotic Polypharmacy among patients with Schizophrenia- characterizing the prescribers

    May 1, 2015, 00:00

  • Potential savings in Healthcare spending on “low-value” interventions- case study of Arthroscopic Knee Surgery

    May 1, 2015, 00:00

  • Economics Of Diabetes Mellitus- Theory And Evidence For Brazilian Data In 2008

    May 1, 2015, 00:00

  • Impact of Dipeptidyl Peptidase-4 Inhibitors on The Risk of Cardiovacular-Related Hsopitalizations

    May 1, 2015, 00:00

  • Small Benefits Of Third Trimester Check-Up Among Pregnant Women Positively Screened For Thyroid Disorders

    May 1, 2015, 00:00

  • Efficacy and Safety of Insulin Analogues Compared to Human Insulin Preparations for the treatment of Patients With Diabetes Type 1 (Dm1)- Systematic Review and Meta-Analysis

    May 1, 2015, 00:00

  • Study of Patient Related outcomes of Type 2 Diabetes and Comparative analysis of pioglitazone sales pre and post ban in Mumbai,India

    May 1, 2015, 00:00

  • Cost of a Pharmacist-Led Pneumonia education and immunization program for older Philadelphians

    May 1, 2015, 00:00

  • Patient’s preferences for dry powder inhaler attributes in Asthma and Chronic Obstructive Pulmonary Disease- a discrete choice experiment

    May 1, 2015, 00:00

  • Patterns of Disease Remission Among Patients With Rheumatoid Arthritis Treated With Biologic Therapies In Japan

    May 1, 2015, 00:00

  • Depression treatment patterns among individuals with Chronic Obstructive Pulmonary disease

    May 1, 2015, 00:00

  • Patient reported outcomes reveal discordance between Patient and Physician assessment of disease burden in patients with Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Diffusion of Ultrasound among Physicians treating patients with Rheumatoid Arthritis- 2002-2013

    May 1, 2015, 00:00

  • A Review of Patient-Reported Outcomes (pros) in Patients with Cutaneous Lupus Erythematosus (CLE)

    May 1, 2015, 00:00

  • Use of Health belief model to understand Knowledge, Attitudes And Behaviors of People Towards The Ebola outbreak

    May 1, 2015, 00:00

  • Pralatrexate Treatment In Patients With Relapsed Or Refractory Peripheral T-Cell Lymphoma- A Systematic Review And Meta-Analysis

    May 1, 2015, 00:00

  • Emergency disease Spectrum in China- based on Hospital database from Beijing

    May 1, 2015, 00:00

  • Patients sent to the emergency department by advanced healthcare providers are more likely to need admission

    May 1, 2015, 00:00

  • Effects of Autologous fat grafting systems on inpatient operating room time and costs- a Hospital budget impact analysis

    May 1, 2015, 00:00

  • Getting The Full Picture- The Importance Of Exrapolating Beyond The Data

    May 1, 2015, 00:00

  • An Analytical Criterion For Judging The Extended Dominancy Of A New Technology Compared To The Standard Of Care And Placebo Control

    May 1, 2015, 00:00

  • Remote monitoring strategies for patients with stable Heart failure- a systematic review and Network meta-analysis

    May 1, 2015, 00:00

  • A Comparison of G-BA’s additional benefit score to NICE ICERs

    May 1, 2015, 00:00

  • Antimicrobial Utilisation in Slovak Hospitals

    May 1, 2015, 00:00

  • Survey of Physicians Regarding Application and utility of Pharmacogenomics Results In the management of chronic medical Conditions

    May 1, 2015, 00:00

  • The impact of alternative Antipsychotic Medications on the risk of adverse events in patients treated for Schizophrenia

    May 1, 2015, 00:00

  • Real-World Practice Patterns For The Treatment Of Complicated Skin And Skin Structure Infections In Europe- A Retrospective Database Analysis

    May 1, 2015, 00:00

  • Demonstrating the cost effectiveness of Movantik for the treatment of opioid induced constipation in Patients with inadequate response to Laxatives; a UK perspective

    May 1, 2015, 00:00

  • Companion devices- transformative Mobile Health Technology towards improved patient care delivery

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian setting

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Meniscal Repair Versus Partial Meniscectomy- A Model-Based Projection of Clinical Outcomes And Costs In The United States Healthcare System

    May 1, 2015, 00:00

  • Oral disease modifying therapy for multiple sclerosis; is this the new normal?

    May 1, 2015, 00:00

  • Meta-Analysis For The Evaluation Of Multiple Surrogate Endpoints

    May 1, 2015, 00:00

  • The Burden of Aml Within the

    May 1, 2015, 00:00

  • Pharmacoepidemiology of Cellular/Tissue derived products for the treatment of Diabetic foot ulcers in outpatient care settings

    May 1, 2015, 00:00

  • When The Literal Meaning Just Won’t Do - Cultural Adaptation Issues Resolved During The Linguistic Validation Of A Behavioural Scale

    May 1, 2015, 00:00

  • Determinants of Pertussis outbreaks and Lessons Learnt

    May 1, 2015, 00:00

  • The rise of the value analysis committee at Us Hospitals, better or worse for medical device companies?

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Smoking Cessation Interventions In Japan Using The Discrete Event Simulation Model

    May 1, 2015, 00:00

  • Impact of Medication Therapy Management (MTM) pilot program on Healthcare Utilization and costs among Texas medicaid patients with Hypertension

    May 1, 2015, 00:00

  • The access and the diffusion of Oncology Drugs in Algeria

    May 1, 2015, 00:00

  • Japan Pricing Methodology Analogue Assessment

    May 1, 2015, 00:00

  • Direct Medical Cost Comparison Between Patients Receiving Cangrelor And Clopidogrel During Percutaneous Coronary Intervention- Champion Phoenix Economic Sub-Study Results

    May 1, 2015, 00:00

  • Impact of non-medical switching on Healthcare costs- a claims database analysis

    May 1, 2015, 00:00

  • Association between informal caregivers’ assistance in management of care-recipients’ medications and their use of training services-a national retrospective study

    May 1, 2015, 00:00

  • Impact of post-surgical complications on Hospital costs and Margins

    May 1, 2015, 00:00

  • Factors Affecting Immunization Timeliness In Malaysia

    May 1, 2015, 00:00

  • The Burden Of Uncertainty In Emergency Room- The Case Of Chest Pain

    May 1, 2015, 00:00

  • Cost Effectiveness of an Anticoagulant Clinic After Introduction Of Noacs For Stroke Prevention In Atrial Fibrillation Patients In the United States

    May 1, 2015, 00:00

  • Patient Preference for Real-Time Feedback In Epro Assessments for Copd Clinical Trials

    May 1, 2015, 00:00

  • Validation And Valuation Of The Preference-Based Healthindex Using Eq-5d-5l In The Hong Kong Population

    May 1, 2015, 00:00

  • Impact of Surgical Site Infections following common Ambulatory Procedures on Healthcare Costs

    May 1, 2015, 00:00

  • Economic Impact of Simulation-Based Training (SBT) for Central Venous Catheter (CVC) Insertion

    May 1, 2015, 00:00

  • Assessment of the Costs and outcomes of Antiretroviral Therapy In Adult Outpatients at a Tertiary Hospital In Harare, Zimbabwe

    May 1, 2015, 00:00

  • Comparison of quantiferon TB-GOLD (QFT-GIT) test versus tuberculin skin test (TST) for latent tuberculosis infection (LTBI) screening among national guard general population in Saudi Arabia

    May 1, 2015, 00:00

  • Prevalence And Predictor Of Antidepressants Use During Pregnancy In The Us- An Nhanes Study

    May 1, 2015, 00:00

  • Readmission Patterns in Medicare Beneficiaries Hospitalized for heart failure

    May 1, 2015, 00:00

  • Cost implication of using Lorcaserin in Weight Management prior to Bariatric Surgery

    May 1, 2015, 00:00

  • Building quality in hta process and decision making- can key performance measures of good practices in hta be identified?

    May 1, 2015, 00:00

  • The Impact of Different Types of Health Insurance on The Hospitalization Services Utilization of Patients With Hemorrhagic Stroke In China

    May 1, 2015, 00:00

  • Are we really measuring access? systematic review of access measures to Medicines in Brazil

    May 1, 2015, 00:00

  • Is visual impairement associated with increased Hospitalization? a retrospective Cohort study of community-dwelling medicare beneficiares

    May 1, 2015, 00:00

  • Cross-state comparison of medicaid Anti-Obesity medication coverage- 1999-2013

    May 1, 2015, 00:00

  • Impact of Medicaid managed care expansion on access to providers in Mississippi

    May 1, 2015, 00:00

  • Mapping Utility Scores from European organization for Treatment of Cancer Core-30 Questionnaire Scores (Eortc Qlq-C30) In Relapsed Multiple Myeloma

    May 1, 2015, 00:00

  • The Processes For A Common Quality Assurance Approach To Multi-Centre Clinical Trials – The Mars Excite Experience

    May 1, 2015, 00:00

  • A Cost-effectiveness Analysis of A biomarker Test Compared to Standard of Care Surveillance in Patients With Barrett’s Esophagus

    May 1, 2015, 00:00

  • HEALTH RELATED QUALITY OF LIFE AND HEALTH CARE RESOURCE USE BURDEN IN MIGRAINE WITH AND WITHOUT NAUSEA

    May 1, 2015, 00:00

  • Cost-Effectiveness of Refractory Asthma Treatment Strategies- A Decision Tree Analysis

    May 1, 2015, 00:00

  • Evaluating Content Validity Of Performance Outcomes (Perfos)- Establishing The Patient-Relevance Of Three Perfos In Elective Total Hip Replacement (Ethr)

    May 1, 2015, 00:00

  • Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

    May 1, 2015, 00:00

  • Communicating risk of Medication side effects- how rare is ‘rare’ and how likely is ‘likely’?

    May 1, 2015, 00:00

  • Effect of Florida’s prescription monitoring Program and pill-mill Laws on Opioid prescribing and Utilization

    May 1, 2015, 00:00

  • Cost-effectiveness of Ikervis® in severe dry Eye disease in the UK

    May 1, 2015, 00:00

  • Important Statistical Considerations For Developing Equations For Disease Simulators

    May 1, 2015, 00:00

  • The Impact of Endoscopic Linear Stapling Device Stability in Thoracic Surgery- a Delphi Panel Approach

    May 1, 2015, 00:00

  • Patient reported outcomes- are they relevant to u.s. Payers?

    May 1, 2015, 00:00

  • Decreasing Ebm order Set review and approval cycle time

    May 1, 2015, 00:00

  • Lessons learned from the Pilot introduction of Peginesatide, a Third generation Erythropoiesis Stimulating Agent

    May 1, 2015, 00:00

  • Exploring Heterogeneity In Attribute Processing Strategies- Use Of Hybrid Random Utility Maximization-Random Regret Minimization (Rum-Rrm) Models In A Discrete Choice Experiment (Dce)

    May 1, 2015, 00:00

  • Cost analysis of patients with acute Coronary event in a Commercial Insurance Company in Colombia —Saludcoop— in 2013

    May 1, 2015, 00:00

  • HIV Antiretroviral drug utilization and Expenditures In Medicaid 1991-2014

    May 1, 2015, 00:00

  • Pneumococcal vaccination Coverage In adults with high-risk Conditions- Missed Opportunities Continue

    May 1, 2015, 00:00

  • Identifying Key factors for Targeting Patients most suitable for Community Health Worker program

    May 1, 2015, 00:00

  • The Use Of Low Molecular Weight Heparin And Pneumatic Compression Devises For Deep Vein Thrombosis Prophylaxis In Major Trauma Patients- A Comparative Effectiveness Analysis

    May 1, 2015, 00:00

  • What factors make Economic Evaluation more valuable as a service?

    May 1, 2015, 00:00

  • Preferences for New Treatments Diminish In The Face of Ambiguity

    May 1, 2015, 00:00

  • Pharmacotherapeutic and Economic indicators of the use of Immunobiologicals Drugs- analysis of a Rheumatic Patient Cohort

    May 1, 2015, 00:00

  • Utilization of Negative Controls to Examine association between Rare Genetic Disorders and Type 2 Diabetes in four Large Observational Databases

    May 1, 2015, 00:00

  • Lack of Adherence to Immunosuppressive Treatment In Kidney Transplant Patients- Estimation of Associated Direct Medical Costs

    May 1, 2015, 00:00

  • WITHDRAWN

    May 1, 2015, 00:00

  • A Review of Clinical outcome Assessments used in FDA approved Drug labels for Mental Health conditions

    May 1, 2015, 00:00

  • Management of tuberous Sclerosis complex in England- insights into Real-World Clinical practice

    May 1, 2015, 00:00

  • Correlation between Pain Catastrophizing scale and disease characteristics in Chronic Low Back Pain Patients

    May 1, 2015, 00:00

  • Agents Acting On Renin-Angiotensin System Usage In Croatia During The Fourteen-Year Period- Impact Of Generics

    May 1, 2015, 00:00

  • Linezolid Prescription Pattern- Identifying the use to Rationalize The Practice

    May 1, 2015, 00:00

  • The budget impact of treating Patients with Non-Diabetic Peripheral Neuropathic Pain (PNP) with capsaicin 8% patch for either Pregabalin-Naive or Pregabalin-Treated Patients in Scotland

    May 1, 2015, 00:00

  • Estimating the cost-effectiveness of left Atrial Appendage closure compared to warfarin for stroke prevention in Atrial Fibrillation

    May 1, 2015, 00:00

  • Analysis of Health Technology assessment requirements in 7 Asia Oceania Countries/regions- comparison of evidentiary requirements for standard and Orphan Drugs

    May 1, 2015, 00:00

  • Quality of Life In Adult Patients with cystic Fibrosis €“ a Systematic Review

    May 1, 2015, 00:00

  • Development and Validation of a clostridium difficile quality of life Questionnaire

    May 1, 2015, 00:00

  • Past trends and current challenges in the hepatitis c reimbursement landscape- is history repeating itself?

    May 1, 2015, 00:00

  • Patients’ Groups And Advocacy In Oncology- Awareness, Support And Unmet Needs

    May 1, 2015, 00:00

  • Cost-Utility Analysis of Apixaban In Patients With Atrial Fibrillation (Af) At The Peruvian Social Security (Essalud)

    May 1, 2015, 00:00

  • Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL)- evaluating the correlation between patient-reported outcomes and durability of response in a Phase 2 study

    May 1, 2015, 00:00

  • Comparing The Eq-5d-3l And Sf-6d Utility Scores Of Acute Coronary Syndrome Patients From An Asian Population

    May 1, 2015, 00:00

  • Biologic Adherence among Psoriasis Patients in the us Medicare Population

    May 1, 2015, 00:00

  • Comparison of real-world hypoglycemia rates among Patients Initiating Treatment with Saxagliptin or Glipizide

    May 1, 2015, 00:00

  • Implementation Of Nice Clinical Guidelines (Cg) – What Can Be Learned From A Uk Case Study And How To Ensure That Health Services Do Not Fall Short Of Their Obligations

    May 1, 2015, 00:00

  • Measurement of Health State Utilities For Relapsed or Refractory Peripheral T-Cell Lymphoma By using time trade-off And Visual Analog Scale Method

    May 1, 2015, 00:00

  • Economic value of preventing central venous catheter sepsis infections with early cannulaton arteriovenous grafts (ECAVGS) compared to Non-Ecavgs

    May 1, 2015, 00:00

  • Efficacy And Safety of Canagliflozin among Patients with type 2 diabetes Mellitus- a Systematic review and meta-analysis

    May 1, 2015, 00:00

  • Utilization and Payment of ERCP-related operations and medical supplies in China BMI inpatients

    May 1, 2015, 00:00

  • Cost Effectiveness of Tofacitinib as Second Line Treatment vs Using Biological Therapies In The Treatment of Moderate Rheumatoid arthritis after Failure of dmards In Panama In 2014

    May 1, 2015, 00:00

  • Is there utility in clinical utility modeling for Diagnostic Technologies?

    May 1, 2015, 00:00

  • Cost-Effectiveness analysis and Budget Impact of an extended Versus Immediate release formulation of Metformin In Type-2 Diabetes mellitus Treatment, from the Perspective of The brazilian Public Health System

    May 1, 2015, 00:00

  • Short- and Long-Term Survival Associated With Laparoscopic Versus open Colectomy In Early-Stage Colon Cancer- Findings From a Retrospective Cohort Study

    May 1, 2015, 00:00

  • Developing Sf-6d-V2- Examining The Dimensionality Of The Sf-36 Using Large Multinational Datasets

    May 1, 2015, 00:00

  • Drug Use Among Seniors On Public Drug Programs In Canada, 2012

    May 1, 2015, 00:00

  • Assessment of Osteoporsis Knowledge And Perception Among Female University Students In Quetta, Pakistan

    May 1, 2015, 00:00

  • Patient Preferences For First-Line Maintenance Treatments For Ovarian Cancer

    May 1, 2015, 00:00

  • Association of Hepatitis C Virus infection with risk of Chronic Kidney Disease- systematic review and meta-analysis

    May 1, 2015, 00:00

  • Rate of adverse event-related treatment changes and Healthcare costs associated with topical Rosacea treatment

    May 1, 2015, 00:00

  • Comparison Of Machine Learning, Statistical And Hybrid Methods To Identify Predictors Of Positive Treatment Outcomes In Comorbid Conditions Using Emr Data

    May 1, 2015, 00:00

  • Rasch analysis of a new Patient reported outcome measure for Psoriasis Treatment (PROMPT)

    May 1, 2015, 00:00

  • Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation

    May 1, 2015, 00:00

  • Directly Eliciting Personal Utility Functions- A New Way To Value Health-Related Quality Of Life

    May 1, 2015, 00:00

  • Clopidogrel Versus Aspirin In Patients With Atherothrombosis- A Caprie-Based Economic Analysis In A Health Resource Limited Setting

    May 1, 2015, 00:00

  • Clinical Trials Registries For Systematic Reviews – An Alternative Source For Unpublished Data

    May 1, 2015, 00:00

  • A Review of intraoperative interventions to prevent staple line leaks and Bleeds during Bariatric Surgical Procedures

    May 1, 2015, 00:00

  • Medication use survey of inpatients with basic Medical Insurance from 2010 to 2012

    May 1, 2015, 00:00

  • Comparative effectiveness of Fibrin sealants in Cardiac Surgery

    May 1, 2015, 00:00

  • Cost-effectiveness of Aflibercept in the treatment of wet age-related Macular Degeneration in Turkey

    May 1, 2015, 00:00

  • Americans’ Cancer Information (CI) Seeking Experiences and Self-Efficacy (SE) in seeking Cancer Information (CI)- a characteristic snapshot using 2012-13 Health Information National Trends Survey (HINTS)

    May 1, 2015, 00:00

  • Comparing The Adoption Of Epro In Clinical Research To Emr In Clinical Practice – Why Clinical Practice Is Ahead Of Research With Technology Use

    May 1, 2015, 00:00

  • Assessing the availability of Drugs marketed in the US and Switzerland

    May 1, 2015, 00:00

  • Health Impact of Trivalent, Trivalent High Dose and Quadrivalent Influenza Vaccines In older adults In ontario, Canada

    May 1, 2015, 00:00

  • Economic and patient burden of Lipohypertrophy in Chinese patients with Diabetes

    May 1, 2015, 00:00

  • Comparative efficacy and Safety of Antidiabetic Drug Regimens Added to Stable and Inadequate metformin and thiazolidinedione therapy In type 2 diabetes

    May 1, 2015, 00:00

  • Is there an impact of the Orphan designation in Oncology on market access in Europe?

    May 1, 2015, 00:00

  • Initial impact of Telepharmacy on specialty Medication adherence

    May 1, 2015, 00:00

  • Cure Models- Accounting For Cured Patients In Economic Evaluations

    May 1, 2015, 00:00

  • Patient-Reported Outcomes (Pros) In Bladder Cancer

    May 1, 2015, 00:00

  • Office-based uterine polypectomy using a minimally invasive Hysteroscopic tissue removal device saves Healthcare resources

    May 1, 2015, 00:00

  • Does treatment for newly-diagnosed depression reduce healthcare expenditures among medicaid beneficiaries with type 2 diabetes mellitus?

    May 1, 2015, 00:00

  • Treatment of Obesity- Pharmacotherapy trends in the United States from 1999 to 2010

    May 1, 2015, 00:00

  • Antihypertensive Drug Utilization In Elderly Outpatients In Serbia

    May 1, 2015, 00:00

  • Cost Effectiveness of Apixaban For Stroke Prevention In Non Valvular Atrial Fibrillation In The Ecuatorian Public Healthcare Sector

    May 1, 2015, 00:00

  • Cost Comparison of First Line Metastatic Renal Cell Carcinoma Treatments Using A Retrospective Claims Dataset

    May 1, 2015, 00:00

  • Clinical characteristics and outcomes of Chronic Hepatitis C (CHC) patients treated with newer Direct-Acting Antiviral (DAA)-based regimens from a large us payer perspective

    May 1, 2015, 00:00

  • Economic implications of increasing usage of Calcium-Free balanced crystalloid solutions (BAL) versus 0.9% saline for intravenous (IV) fluid Therapy in patients with Systemic Inflammatory Response Syndrome (SIRS) in us Hospitals

    May 1, 2015, 00:00

  • Safety of Tofacitinib Compared to Biological Dmards In Rheumatoid Arthritis Patients With An Inadequate Response to Methotrexate- overview of Systematic Reviews

    May 1, 2015, 00:00

  • Cost effectiveness of Antiglaucoma medications

    May 1, 2015, 00:00

  • Temporal Trend and Prevalence of Ckd Stages (Kdigo 2012) in Us Adults with Type 2 Diabetes Mellitus and demographic Subgroups- Nhanes 2007-2012

    May 1, 2015, 00:00

  • Burden of Disease and Economic Impact of Malaria In Colombia, 2012

    May 1, 2015, 00:00

  • A Cost Comparison of Split-Dose Reduced-Volume oral Sulfate Solution (OSS) And Polyethylene Glycol With Electrolytes Solution (Peg-Els)

    May 1, 2015, 00:00

  • An Evaluation Of Competing Models For Predicting Cv Event Rates From Ldl-C Levels In Secondary Prevention

    May 1, 2015, 00:00

  • Who is spending where- analysis of Healthcare spending by Medicaid and Private Payers in Massachusetts

    May 1, 2015, 00:00

  • Estimation of direct healthcare costs of gynecologic cancer in the u.s.- an analysis of 2007-2011 medical expenditure panel survey (meps) data

    May 1, 2015, 00:00

  • A Comparative Cost Utility Analysis For First Line Treatment Of Metastatic Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Exon 19 Deletions Or Exon 21 (L858r) Substitution Mutations

    May 1, 2015, 00:00

  • Hta Decisions And Comparator Changes Over Time In Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Derivation of A Preference-Based Measure for Metastatic Breast Cancer Using The Eortc Qlq-30 And Qlq-Br 23

    May 1, 2015, 00:00

  • Risk of Glucocorticoid-related adverse events in Patients with Systemic Lupus Erythematous- findings from a 12-year Longitudinal follow-up study in Taiwan

    May 1, 2015, 00:00

  • Evaluation Of Matching-Adjusted Indirect Comparison Implemented By A Resampling Method

    May 1, 2015, 00:00

  • Prospective Study On Prescription Pattern In Tertiary Care Hospital In South India

    May 1, 2015, 00:00

  • Use of multiple concurrent Antipsychotics in Children enrolled in the Mississippi Medicaid Program

    May 1, 2015, 00:00

  • Trajectories of Buprenorphine treatment and Associated Emergency Department and inpatient use in a large Medicaid Program

    May 1, 2015, 00:00

  • Economic burden of vaccine-preventable diseases among the elderly in Taiwan

    May 1, 2015, 00:00

  • Specificity and Sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica- a Meta-Analysis

    May 1, 2015, 00:00

  • A Retrospective Analysis of the Economic Burden Among Patients Diagnosed with Chronic Migraine using the Veterans Health Administration Medical data

    May 1, 2015, 00:00

  • Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data

    May 1, 2015, 00:00

  • Increasing Households’ Access To Healthcare; Linking Clinicians To Community Health Workers Through Counter Referral Comments

    May 1, 2015, 00:00

  • Guidance For The Conduct And Reporting Of Modeling And Simulation In The Context Of Health Technology Assessment

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination In Mainland China

    May 1, 2015, 00:00

  • Physician’s Adherence To Treatment Guidelines In Deep Vein Thrombosis At An Indian Tertiary Healthcare Facility

    May 1, 2015, 00:00

  • Cost – Efficacy Study for Ipilimumab in the Chilean Market

    May 1, 2015, 00:00

  • Psychometric Validation Of Performance Outcomes (Perfos) For Use With Hip Fracture (Hf) Populations

    May 1, 2015, 00:00

  • Cost-Effectiveness Of Riociguat For Treatment Of Patients With Inoperable Or Post-Operative Recurrent/Persistent Chronic Thromboembolic Pulmonary Hypertension (Cteph) In Turkey

    May 1, 2015, 00:00

  • Comparative outcomes of Testosterone therapy versus no Treatment in hypogonadic men

    May 1, 2015, 00:00

  • Point-of-care, real-time decision support tools- a pathway compliance solution but only when they are used

    May 1, 2015, 00:00

  • Real-World adherence in Medicare Patients with type 2 Diabetes Mellitus (T2dm) for exenatide qw and Liraglutide qd

    May 1, 2015, 00:00

  • Uterine fibroid treatment patterns in the three years following Diagnosis

    May 1, 2015, 00:00

  • Costs Description of Rheumatoid Arthritis Treatment In Chile For Patients Who Have Failed To Conventional Synthetic Dmards

    May 1, 2015, 00:00

  • Impact of Patient reported outcomes on Medication Therapy Management for High-Cost Specialty Drugs

    May 1, 2015, 00:00

  • Status Of Maternal Depression In Relation To Health-Related Quality Of Life For Pregnant Women In China- Results From A Hospital-Based Survey

    May 1, 2015, 00:00

  • Epidemiology of advanced Therapies for the treatment of Diabetic foot ulcers in outpatient care settings

    May 1, 2015, 00:00

  • Validity And Limitations Of The Longitudinal Patient Database France For Use In Pharmacoepidemiological And Pharmacoeconomics Studies

    May 1, 2015, 00:00

  • Data Extraction For Systematic Review – Where To Look For Data Outside The Primary Publication

    May 1, 2015, 00:00

  • Comparing tyrosine kinase inhibitor treatment strategies for newly diagnosed chronic myeloid leukemia in chronic phase when imatinib loses patent exclusivity in the u.s.- a cost-effectiveness analysis

    May 1, 2015, 00:00

  • Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer

    May 1, 2015, 00:00

  • Healthcare resource utilization associated with rescue Medication use in adult Patients With Seizure Clusters- a retrospective chart Review

    May 1, 2015, 00:00

  • Evidence of a gap in care- utilization of Radiologic Diagnostic imaging in patients with and without implantable defibrillators

    May 1, 2015, 00:00

  • Study of Psychological stress and ACNE vulgaris among Pharmacy Students

    May 1, 2015, 00:00

  • Estimating Quality of Life of Patients with Lipodystrophy

    May 1, 2015, 00:00

  • The Impact of Access to Cancer Care on Adjuvant Endocrine Therapy Use Among Breast Cancer Survivors in Appalachia

    May 1, 2015, 00:00

  • Modeling of Societal Costs Under Different Treatment Schemes of Post-Stroke Spasticity In The Russian Federation

    May 1, 2015, 00:00

  • Matching-Adjusted Indirec Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc)

    May 1, 2015, 00:00

  • Long-term impact of a Pharmacist-Led Diabetes medication management program on Glycemic control

    May 1, 2015, 00:00

  • Canadian retrospective claims data analysis of Biologics switching and retention patterns in Psoriasis Patients

    May 1, 2015, 00:00

  • MEDICATION COST IMPLICATION FOR THE MANAGEMENT OF HYPERTENSION AND DIABETES IN NIGER DELTA- TERTIARY HOSPITAL BASED STUDY IN BAYELSA STATE, NIGERIA

    May 1, 2015, 00:00

  • Real-World Statin Utilization Among Patients At High Risk for Cardiovascular Events- Us Analyses

    May 1, 2015, 00:00

  • Once-Daily Single-tablet Regimen Reduce Loss to Follow-up In People Living With Hiv

    May 1, 2015, 00:00

  • Examining the impact of a Hybrid Clinical Pharmacy practice model on medication adherence in patients with Metabolic Syndrome

    May 1, 2015, 00:00

  • Venous Thromboembolism Prevalence In French And Us Hospitals- Comparison On The Basis Of The National Data Bases

    May 1, 2015, 00:00

  • Relationship between the development of Electronic Health records and Hospital accreditation decisions in Fran results from the E-SI (preps-sips) study

    May 1, 2015, 00:00

  • Forecasting the United States Lifetime Cost and outcomes of Ivacaftor in Patients with Cystic Fibrosis

    May 1, 2015, 00:00

  • Increasing prevalence of ctx-m, tem and shv beta-lactamases in clinical pathogenic e. Coli causes significant health and economic losses- a perspective from pakistan

    May 1, 2015, 00:00

  • Patient Registries In India – National Cancer Registry Program

    May 1, 2015, 00:00

  • Study On The Inpatient Hospital Costs Of Hemorrhagic Stroke Inpatients In China

    May 1, 2015, 00:00

  • Contextual analysis of determinants of late Diagnosis of Hepatitis C Virus infection in medicare patients

    May 1, 2015, 00:00

  • OUTCOMES AND HEALTH RESOURCE UTILIZATION AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AT AN ACADEMIC MEDICAL CENTER (AMC) IN THE UNITED STATES

    May 1, 2015, 00:00

  • Improved Health Care outcomes and Cost Savings for Asthma Through Targeted Home Interventions

    May 1, 2015, 00:00

  • Resource Utilization and costs associated with off-label use of atypical Antipsychotics in a Community-Dwelling Adult Population- findings from the Medical Expenditure Survey

    May 1, 2015, 00:00

  • Cost Effectiveness Of Statins In Primary Prevention Of Coronary Heart Disease- A Systematic Review And Quality Assessment Of Economic Evidence To Elucidate Recent Trends In Usa

    May 1, 2015, 00:00

  • Interventions For Ultra-Rare Disorders (Urds) And The Logic Of Cost Effectiveness

    May 1, 2015, 00:00

  • Real-world treatment patterns of antihyperglycemic agents among patients with type 2 diabetes melltus (T2dm) Initiated on canagliflozin

    May 1, 2015, 00:00

  • Availability and affordability of Antiglaucoma Drugs in Benin City, Nigeria

    May 1, 2015, 00:00

  • “Would You Like An All-Inclusive Luxury Holiday With First Class Flights To Egypt With Your Sovaldi Prescription” - Innovative Cost-Saving Solutions For Us Payers

    May 1, 2015, 00:00

  • Development and validation of a u.s. Administrative claims-based algorithm to classify patients with type 2 diabetes mellitus into renal impairment stages

    May 1, 2015, 00:00

  • Healthcare resource use among Patients with congestive Heart failure in a Large Health Organization

    May 1, 2015, 00:00

  • Anticholinergic Medication use and risk of incident Fractures in the elderly with Depression

    May 1, 2015, 00:00

  • Estimating the cost-Effectiveness of 12 weeks of treatment with Daclatasvir+Sofosbuvir In Patients Chronically Infected With hcv Genotype 3

    May 1, 2015, 00:00

  • The Californian Technology assessment forum – the arrival of cost-utility appraisals of Drugs in the USA?

    May 1, 2015, 00:00

  • A Descriptive Analysis of Patient Characteristics, Bleeding And Recurrence Risk Among U.S Veteran Patients Diagnosed With Venous Thromboembolism

    May 1, 2015, 00:00

  • Economic Impact Of Changes In Nicu Ventilation Strategies With The Advent Of New Noninvasive Ventilation Techniques- A Review And Proposed Assessment Framework For High Flow Therapy (Hft) As A Routine Respiratory Support Paradigm

    May 1, 2015, 00:00

  • Dosing pattern analysis for Biologics in the treatment of Psoriasis in Canada- indication-specific information retrieved from Administrative Claims Database

    May 1, 2015, 00:00

  • Sample Structure In A Prospective Study Of 22,000 Women Using Hormone Replacement Therapy (Hrt) Retained Unbiased After A Five-Year Follow-Up

    May 1, 2015, 00:00

  • Perceptions of community Pharmacists about their current professional role, inter professional learning and continue professional development in Pakistan

    May 1, 2015, 00:00

  • Colorectal Cancer (CRC) costs in the us- findings from the Medical Expenditure Panel Survey 2008-2012

    May 1, 2015, 00:00

  • Combining Mcda With Advanced Statistics To Tackle Challenges Of Data And Judgment Uncertainty- Case Study Of Safety Assessments

    May 1, 2015, 00:00

  • Assessing the impact of varying threshold criteria for Opioid Overutilization

    May 1, 2015, 00:00

  • Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2- Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force

    Mar 1, 2015, 00:00

  • Strengthening Tuberculosis Control Overseas- Who Benefits?

    Mar 1, 2015, 00:00

  • Editorial Board

    Mar 1, 2015, 00:00

  • Cost-Utility Analyses in Diabetes- A Systematic Review and Implications from Real-World Evidence

    Mar 1, 2015, 00:00

  • Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions

    Mar 1, 2015, 00:00

  • The Changing Face of the Cost-Utility Literature, 1990–2012

    Mar 1, 2015, 00:00

  • A Unified Framework for Classification of Methods for Benefit-Risk Assessment

    Mar 1, 2015, 00:00

  • Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

    Mar 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis

    Mar 1, 2015, 00:00

  • Clinical Trials Provide Essential Evidence, but Rarely Offer a Vehicle for Cost-Effectiveness Analysis

    Mar 1, 2015, 00:00

  • Instructions for Authors

    Mar 1, 2015, 00:00

  • Copyright/Subscription

    Mar 1, 2015, 00:00

  • Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicular Lymphoma

    Mar 1, 2015, 00:00

  • Learning and Satisficing- An Analysis of Sequence Effects in Health Valuation

    Mar 1, 2015, 00:00

  • Application of Multicategory Exposure Marginal Structural Models to Investigate the Association between Long-Acting Beta-Agonists and Prescribing of Oral Corticosteroids for Asthma Exacerbations in the Clinical Practice Research Datalink

    Mar 1, 2015, 00:00

  • Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment

    Mar 1, 2015, 00:00
  • «
  • 101
  • 102
  • 103 (current)
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • »